SEC 13F Intelligence

Arthur M. Cohen & Associates, LLC / LLY

Arthur M. Cohen & Associates, LLC’s Eli Lilly & Co Position

Does Arthur M. Cohen & Associates, LLC own Eli Lilly & Co (LLY)? Yes22.2K shares worth $21M (+3.76% of its 13F portfolio) as of Q1 2026, down from 22.5K shares the prior filed quarter.

Position Value
$21M
Q1 2026
Shares
22.2K
% of Portfolio
+3.76%
Quarters Held
30
currently held

Position History LLY

Reported value by quarter
Q4 ’18: $6MQ4 ’18Q1 ’19: $6MQ2 ’19: $5MQ3 ’19: $5MQ4 ’19: $6MQ4 ’19Q1 ’20: $6MQ2 ’20: $8MQ3 ’20: $7MQ4 ’20: $8MQ4 ’20Q1 ’21: $9MQ2 ’21: $11MQ3 ’21: $11MQ4 ’21: $13MQ4 ’21Q1 ’22: $11MQ2 ’22: $13MQ3 ’22: $12MQ4 ’22: $12MQ4 ’22Q1 ’23: $11MQ2 ’23: $14MQ3 ’23: $16MQ4 ’23: $16MQ4 ’23Q1 ’24: $20MQ2 ’24: $23MQ3 ’24: $23MQ4 ’24: $19MQ4 ’24Q1 ’25: $19MQ2 ’25: $18MQ3 ’25: $17MQ4 ’25: $24MQ4 ’25Q1 ’26: $21Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202622.2K$21M+3.76%
Q4 202522.5K$24M+3.95%
Q3 202522.8K$17M+2.93%
Q2 202522.7K$18M+3.13%
Q1 202523.6K$19M+3.74%
Q4 202424.2K$19M+3.31%
Q3 202425.5K$23M+4.07%
Q2 202425.8K$23M+4.28%
Q1 202426.0K$20M+4.29%
Q4 202326.9K$16M+3.68%
Q3 202329.2K$16M+4.01%
Q2 202330.2K$14M+3.52%
Q1 202331.2K$11M+2.87%
Q4 202233.5K$12M+3.35%
Q3 202237.8K$12M+3.36%
Q2 202239.3K$13M+3.21%
Q1 202240.0K$11M+2.42%
Q4 202145.5K$13M+2.33%
Q3 202146.8K$11M+2.19%
Q2 202147.0K$11M+2.09%
Q1 202126.6K$9M+2.02%
Q4 202046.7K$8M+1.85%
Q3 202046.7K$7M+1.79%
Q2 202046.0K$8M+2.38%
Q1 202046.0K$6M+2.49%
Q4 201946.4K$6M+1.87%
Q3 201948.2K$5M+1.52%
Q2 201946.9K$5M+1.80%
Q1 201949.0K$6M+2.27%
Q4 201849.4K$6M+1.82%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Arthur M. Cohen & Associates, LLC’s full portfolio or all institutional holders of LLY.